Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers

Immunotherapy

Recent progress in therapeutic antibodies for cancer immunotherapy

doi: 10.1016/j.cbpa.2018.05.006.

Immunotherapy

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations

Hum Vaccin Immunother.

Gatti-Mays ME, Redman JM, Collins JM, Bilusic M

doi: 10.1080/21645515.

Melanoma and Skin CancerImmunotherapy

Identification of essential genes for cancer immunotherapy

Nature.

Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP

doi: 10.1038/nature23477.

Melanoma and Skin CancerImmunotherapy

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Biomaterials

Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J

doi: 10.1016/j.biomaterials.

Immunotherapy

Novel immunotherapy strategies for hepatobiliary cancers

Immunotherapy.

DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ

doi: 10.2217/imt-2018-0024.

Melanoma and Skin Cancer

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Int Immunopharmacol.

Caisová V, Uher O, Nedbalová P, Jochmanová I, Kvardová K, Masáková K, Krejčová G, Paďouková L, Chmelař J, Kopecký J, Ženka J

doi: 10.1016/

Immunotherapy

Immunotherapy in Gastrointestinal Cancers

Biomed Res Int.

Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, Zagonel V, Lonardi S

doi: 10.1155/2017/4346576.

T Cells

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Semin Cancer Biol.

Kumar P, Saini S, Prabhakar BS

doi: 10.1016/j.semcancer.

Immunotherapy

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy

Front Oncol.

Le Bourgeois T, Strauss L, Aksoylar HI, Daneshmandi S, Seth P, Patsoukis N, Boussiotis VA

doi: 10.3389/fonc.2018.00237.

Related content

Recent progress in therapeutic antibodies for cancer immunotherapy

Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations

Identification of essential genes for cancer immunotherapy

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Novel immunotherapy strategies for hepatobiliary cancers

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Immunotherapy in Gastrointestinal Cancers

Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy